Omthera proposes IPO

Omthera Pharmaceuticals Inc., Bedminster, N.J. Business: Endocrine/Metabolic Date announced: 3/11/13 Type: IPO To be raised: Up to $75 million Shares: TBD Price: TBD Underwriters: BofA Merrill Lynch; ...